ArticleJournal of pharmacy & bioallied sciences2024
Eggshell Derived Nanohydroxyapatite as a Bone Graft for Intrabony Defects was Evaluated Using (CBCT) - A Randomized Controlled Trial.
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- A comparative evaluation of eggshell derived hydroxyapatite and demineralized freeze-dried bone allograft in alveolar ridge preservation - a randomized clinical trial.Biomaterial investigations in dentistry · 2025Article
- Comparative evaluation of the effectiveness of a novel composite bone substitute synthesized from eggshell-derived hydroxyapatite and fish collagen in bone regeneration of critical-sized calvarial defects in Wistar rats.Frontiers in dental medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: The study aims to assess the effectiveness of eggshell-derived nanohydroxyapatite (EnHA) as a bone graft material for treating intrabony defects, using cone-beam computed tomography (CBCT) for evaluation. Materials and Methods: Ten patients were divided into two groups: Group 1: individuals with 2-wall defects, Group 2: those with 3-wall defects. Follow-up appointments at 1-, 3-, and 6-month intervals included assessments of clinical attachment level (CAL), probing depth (PD), and gingival recession (GR). CBCT scans were conducted pre-operative, immediately post-surgery, and at 1-month, 3-month, and 5-month follow-ups. Results: In both groups, clinical parameters such as CAL, PD, and CBCT measurements reveal significant decreases in CAL and PD values alongside positive trends in CBCT measurements. Additionally, Group 2 exhibited enhancements in periodontal health, suggesting the potential effectiveness of EnHA. Conclusion: EnHA demonstrates potential as a substitute for bone grafting in intrabony defects, showing favourable trends in both clinical and CBCT evaluations during a 6-month observation period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.